Rebecca Mancusi is an accomplished biotech advisor with expertise in guiding early-stage ventures which integrate key stakeholders across biotech, venture capital, medicine, and academia. With over 10 years of experience, she has guided companies in oncology, RNA therapeutics, and peptide therapeutics, advancing scientific strategy and positioning companies for successful fundraising rounds. Her work has involved establishment of preclinical models, management of large-scale data analytics workstreams, competitive due diligence, and financial modeling. Rebecca is heavily involved in various entrepreneurial and professional networks, including the Association for Women in Science, Evexia BioFund, Nucleate Activator Program, and the Stanford SPARK Program. 

 

Currently completing the final year of her Ph.D. in Cancer Biology at Stanford, Rebecca is excited to bring her expertise to Atoll Financial Group as a Research Associate working with the Biotech and Life Sciences team identifying promising technologies and providing scientific and strategic guidance to the banking team when developing investment theses for clients.